{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,8]],"date-time":"2026-03-08T03:59:45Z","timestamp":1772942385643,"version":"3.50.1"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82205032"],"award-info":[{"award-number":["82205032"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","prd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Parkinsonism &amp; Related Disorders"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.parkreldis.2025.108018","type":"journal-article","created":{"date-parts":[[2025,9,5]],"date-time":"2025-09-05T00:18:50Z","timestamp":1757031530000},"page":"108018","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Potential causal association between immune cells, metabolites and Parkinson's disease: A mediation Mendelian randomization study"],"prefix":"10.1016","volume":"140","author":[{"given":"Yize","family":"Sun","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zetai","family":"Bai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zheyi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.parkreldis.2025.108018_bib1","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1002\/mds.26424","article-title":"MDS clinical diagnostic criteria for Parkinson's disease","volume":"30","author":"Postuma","year":"2015","journal-title":"Mov. Disord. : Off. J. Movement Dis. Soc."},{"issue":"8","key":"10.1016\/j.parkreldis.2025.108018_bib2","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s11910-022-01207-5","article-title":"Neurodegeneration and neuroinflammation in Parkinson's disease: a self-sustained loop","volume":"22","author":"Arena","year":"2022","journal-title":"Curr. Neurol. Neurosci. Rep."},{"issue":"7","key":"10.1016\/j.parkreldis.2025.108018_bib3","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1001\/jamaneurol.2017.0469","article-title":"Genome-wide pleiotropy between parkinson disease and autoimmune diseases","volume":"74","author":"Witoelar","year":"2017","journal-title":"JAMA Neurol."},{"issue":"22","key":"10.1016\/j.parkreldis.2025.108018_bib4","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21228421","article-title":"Neurodegeneration and Inflammation-An interesting interplay in Parkinson's disease","volume":"21","author":"Marogianni","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"11","key":"10.1016\/j.parkreldis.2025.108018_bib5","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1038\/s41577-022-00684-6","article-title":"Inflammation and immune dysfunction in Parkinson disease","volume":"22","author":"Tansey","year":"2022","journal-title":"Nat. Rev. Immunol."},{"issue":"1","key":"10.1016\/j.parkreldis.2025.108018_bib6","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s13024-018-0304-2","article-title":"Recent advances and perspectives of metabolomics-based investigations in Parkinson's disease","volume":"14","author":"Shao","year":"2019","journal-title":"Mol. Neurodegener."},{"issue":"1","key":"10.1016\/j.parkreldis.2025.108018_bib7","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s13024-020-00408-1","article-title":"Glycosphingolipids and neuroinflammation in Parkinson's disease","volume":"15","author":"Belarbi","year":"2020","journal-title":"Mol. Neurodegener."},{"issue":"1","key":"10.1016\/j.parkreldis.2025.108018_bib8","first-page":"59","article-title":"Genome-wide association studies","volume":"1","author":"Uffelmann","year":"2021"},{"issue":"10","key":"10.1016\/j.parkreldis.2025.108018_bib9","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1038\/s41588-020-0684-4","article-title":"Complex genetic signatures in immune cells underlie autoimmunity and inform therapy","volume":"52","author":"Orr\u00f9","year":"2020","journal-title":"Nat. Genet."},{"key":"10.1016\/j.parkreldis.2025.108018_bib10","article-title":"Causal relationship between immune cells and neurodegenerative diseases: a two-sample Mendelian randomisation study","volume":"15","author":"Tang","year":"2024","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.parkreldis.2025.108018_bib11","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/s41588-022-01270-1","article-title":"Genomic atlas of the plasma metabolome prioritizes metabolites implicated in human diseases","volume":"55","author":"Chen","year":"2023","journal-title":"Nat. Genet."},{"issue":"12","key":"10.1016\/j.parkreldis.2025.108018_bib12","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/S1474-4422(19)30320-5","article-title":"Identification of novel risk loci, causal insights, and heritable risk for Parkinson's disease: a meta-analysis of genome-wide association studies","volume":"18","author":"Nalls","year":"2019","journal-title":"Lancet Neurol."},{"issue":"1","key":"10.1016\/j.parkreldis.2025.108018_bib13","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s12974-023-02999-0","article-title":"Gut microbiota, circulating cytokines and dementia: a Mendelian randomization study","volume":"21","author":"Ji","year":"2024","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.parkreldis.2025.108018_bib14","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.34408","article-title":"The MR-Base platform supports systematic causal inference across the human phenome","volume":"7","author":"Hemani","year":"2018","journal-title":"eLife"},{"issue":"7","key":"10.1016\/j.parkreldis.2025.108018_bib15","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1002\/gepi.21758","article-title":"Mendelian randomization analysis with multiple genetic variants using summarized data","volume":"37","author":"Burgess","year":"2013","journal-title":"Genet. Epidemiol."},{"issue":"2","key":"10.1016\/j.parkreldis.2025.108018_bib16","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a038984","article-title":"Multivariable mendelian randomization and mediation","volume":"11","author":"Sanderson","year":"2021","journal-title":"Cold Spring Harb. Perspect. Med."},{"issue":"4","key":"10.1016\/j.parkreldis.2025.108018_bib17","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1093\/aje\/kwu283","article-title":"Multivariable Mendelian randomization: the use of pleiotropic genetic variants to estimate causal effects","volume":"181","author":"Burgess","year":"2015","journal-title":"Am. J. Epidemiol."},{"issue":"3","key":"10.1016\/j.parkreldis.2025.108018_bib18","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.jclinepi.2014.09.005","article-title":"Cochran's Q test was useful to assess heterogeneity in likelihood ratios in studies of diagnostic accuracy","volume":"68","author":"Cohen","year":"2015","journal-title":"J. Clin. Epidemiol."},{"issue":"5","key":"10.1016\/j.parkreldis.2025.108018_bib19","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s10654-017-0255-x","article-title":"Interpreting findings from Mendelian randomization using the MR-Egger method","volume":"32","author":"Burgess","year":"2017","journal-title":"Eur. J. Epidemiol."},{"issue":"4","key":"10.1016\/j.parkreldis.2025.108018_bib20","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1007\/s00401-021-02268-5","article-title":"Periphery and brain, innate and adaptive immunity in Parkinson's disease","volume":"141","author":"Harms","year":"2021","journal-title":"Acta Neuropathol."},{"issue":"7","key":"10.1016\/j.parkreldis.2025.108018_bib21","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1002\/mds.29432","article-title":"The endotoxin hypothesis of Parkinson's disease","volume":"38","author":"Brown","year":"2023","journal-title":"Mov. Disord. : Off. J. Movement Dis. Soc."},{"key":"10.1016\/j.parkreldis.2025.108018_bib22","doi-asserted-by":"crossref","first-page":"870","DOI":"10.3389\/fneur.2018.00870","article-title":"Monocyte function in Parkinson's disease and the impact of autologous serum on phagocytosis","volume":"9","author":"Wijeyekoon","year":"2018","journal-title":"Front. Neurol."},{"issue":"s1","key":"10.1016\/j.parkreldis.2025.108018_bib23","doi-asserted-by":"crossref","first-page":"S149","DOI":"10.3233\/JPD-223245","article-title":"Neuroinflammation and immune changes in prodromal Parkinson's disease and other synucleinopathies","volume":"12","author":"Terkelsen","year":"2022","journal-title":"J. Parkinsons Dis."},{"issue":"1","key":"10.1016\/j.parkreldis.2025.108018_bib24","doi-asserted-by":"crossref","first-page":"7529","DOI":"10.1038\/s41467-023-43224-z","article-title":"Brain-to-gut trafficking of alpha-synuclein by CD11c(+) cells in a mouse model of Parkinson's disease","volume":"14","author":"McFleder","year":"2023","journal-title":"Nat. Commun."},{"issue":"9","key":"10.1016\/j.parkreldis.2025.108018_bib25","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1134\/S0006297918090122","article-title":"Immunogenetic factors of neurodegenerative diseases: the role of HLA class II, biochemistry","volume":"83","author":"Aliseychik","year":"2018","journal-title":"Biokhimiia"},{"issue":"1","key":"10.1016\/j.parkreldis.2025.108018_bib26","doi-asserted-by":"crossref","first-page":"177","DOI":"10.3233\/JAD-150217","article-title":"Expression of HLA-DR, CD80, and CD86 in healthy aging and Alzheimer's disease","volume":"47","author":"Busse","year":"2015","journal-title":"J. Alzheim. Dis. : JAD"},{"key":"10.1016\/j.parkreldis.2025.108018_bib27","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.jneuroim.2017.04.007","article-title":"Staining of HLA-DR, Iba1 and CD68 in human microglia reveals partially overlapping expression depending on cellular morphology and pathology","volume":"309","author":"Hendrickx","year":"2017","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.parkreldis.2025.108018_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2019.104589","article-title":"Altered microglia and neurovasculature in the Alzheimer's disease cerebellum","volume":"132","author":"Singh-Bains","year":"2019","journal-title":"Neurobiol. Dis."},{"issue":"1","key":"10.1016\/j.parkreldis.2025.108018_bib29","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/s13195-015-0139-9","article-title":"Immune phenotypes of microglia in human neurodegenerative disease: challenges to detecting microglial polarization in human brains","volume":"7","author":"Walker","year":"2015","journal-title":"Alzheimers Res. Ther."},{"issue":"5","key":"10.1016\/j.parkreldis.2025.108018_bib30","doi-asserted-by":"crossref","first-page":"e16","DOI":"10.1182\/blood-2010-12-326355","article-title":"Gene expression profiling reveals the defining features of the classical, intermediate, and nonclassical human monocyte subsets","volume":"118","author":"Wong","year":"2011","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.parkreldis.2025.108018_bib31","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.humimm.2019.11.003","article-title":"Characteristics of circulating monocytes at baseline and after activation in patients with intracranial aneurysm","volume":"81","author":"Wang","year":"2020","journal-title":"Hum. Immunol."},{"issue":"6","key":"10.1016\/j.parkreldis.2025.108018_bib32","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1038\/s41582-020-0344-4","article-title":"Parkinson disease and the immune system - associations, mechanisms and therapeutics","volume":"16","author":"Tan","year":"2020","journal-title":"Nat. Rev. Neurol."},{"issue":"9","key":"10.1016\/j.parkreldis.2025.108018_bib33","doi-asserted-by":"crossref","DOI":"10.3390\/biom11091311","article-title":"The multiple roles of sphingomyelin in Parkinson's disease","volume":"11","author":"Signorelli","year":"2021","journal-title":"Biomolecules"},{"issue":"10","key":"10.1016\/j.parkreldis.2025.108018_bib34","doi-asserted-by":"crossref","first-page":"3472","DOI":"10.1093\/brain\/awac176","article-title":"Lipid pathway dysfunction is prevalent in patients with Parkinson's disease","volume":"145","author":"Galper","year":"2022","journal-title":"Brain : J. Neurol."},{"issue":"1","key":"10.1016\/j.parkreldis.2025.108018_bib35","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1038\/s42003-022-04011-6","article-title":"Multi-omic analyses characterize the ceramide\/sphingomyelin pathway as a therapeutic target in Alzheimer's disease","volume":"5","author":"Baloni","year":"2022","journal-title":"Commun. Biol."},{"key":"10.1016\/j.parkreldis.2025.108018_bib36","doi-asserted-by":"crossref","first-page":"437","DOI":"10.3389\/fneur.2020.00437","article-title":"Exploring sphingolipid implications in neurodegeneration","volume":"11","author":"Alessenko","year":"2020","journal-title":"Front. Neurol."},{"issue":"9","key":"10.1016\/j.parkreldis.2025.108018_bib37","doi-asserted-by":"crossref","DOI":"10.3390\/cells9091966","article-title":"Explorative combined lipid and transcriptomic profiling of substantia nigra and putamen in Parkinson's disease","volume":"9","author":"Xicoy","year":"2020","journal-title":"Cells"},{"issue":"5","key":"10.1016\/j.parkreldis.2025.108018_bib38","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines9050491","article-title":"Alteration in the cerebrospinal fluid lipidome in Parkinson's disease: a post-mortem pilot study","volume":"9","author":"Fern\u00e1ndez-Irigoyen","year":"2021","journal-title":"Biomedicines"},{"issue":"1","key":"10.1016\/j.parkreldis.2025.108018_bib39","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/s41531-024-00632-2","article-title":"A protective role of ABCA5 in response to elevated sphingomyelin levels in Parkinson's disease","volume":"10","author":"Fu","year":"2024","journal-title":"npj Parkinson's Dis."},{"key":"10.1016\/j.parkreldis.2025.108018_bib40","doi-asserted-by":"crossref","first-page":"200","DOI":"10.3389\/fnmol.2019.00200","article-title":"Inhibition of nSMase 2 reduces the transfer of Oligomeric \u03b1-Synuclein irrespective of hypoxia","volume":"12","author":"Sackmann","year":"2019","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.parkreldis.2025.108018_bib41","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/5392966","article-title":"Chronic cerebral hypoperfusion aggravates Parkinson's disease dementia-like symptoms and pathology in 6-OHDA-Lesioned rat through interfering with sphingolipid metabolism","volume":"2022","author":"Fan","year":"2022","journal-title":"Oxid. Med. Cell. Longev."},{"issue":"1","key":"10.1016\/j.parkreldis.2025.108018_bib42","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.immuni.2020.09.014","article-title":"Modification of proteins by metabolites in immunity","volume":"54","author":"Diskin","year":"2021","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.parkreldis.2025.108018_bib43","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/s41556-018-0217-x","article-title":"Metabolism as a guiding force for immunity","volume":"21","author":"Jung","year":"2019","journal-title":"Nat. Cell Biol."}],"container-title":["Parkinsonism &amp; Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S135380202500759X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S135380202500759X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T11:44:44Z","timestamp":1772883884000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S135380202500759X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":43,"alternative-id":["S135380202500759X"],"URL":"https:\/\/doi.org\/10.1016\/j.parkreldis.2025.108018","relation":{},"ISSN":["1353-8020"],"issn-type":[{"value":"1353-8020","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Potential causal association between immune cells, metabolites and Parkinson's disease: A mediation Mendelian randomization study","name":"articletitle","label":"Article Title"},{"value":"Parkinsonism & Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.parkreldis.2025.108018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"108018"}}